Financial Information

This section of the Co-Diagnostics InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Co-Diagnosticsassumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQCODX
Beta(1.97)
Shares Outstanding28.9M
Average Volume (10 days)2.7M
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)$1.75
Sales (TTM)$2.39
Book Value (MRQ)$2.64
Cash Flow (TTM)$1.40
Cash (MRQ)$2.10

Analyst Views

Current Mean RecommendationBuy
Strong Buy1
 
Buy0
 
Hold1
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Brian L. Brown
Chief Financial Officer
5,000
Acquire
May 24, 2021
Dwight H Egan
Director, Chief Executive Officer
(5,628)
Dispose
May 24, 2021
Brian L. Brown
Chief Financial Officer
(1,524)
Dispose
May 24, 2021
Dwight H Egan
Director, Chief Executive Officer
12,500
Acquire
May 24, 2021
Reed L. Benson
General Counsel
4,584
Acquire
May 24, 2021

Recent SEC Filings

Amended >= 5% Acquisition
Jul 12, 2021
Company Events
Jul 9, 2021
Proxy Statement
Jun 22, 2021
Insider Buy/Sell
May 26, 2021
Insider Buy/Sell
May 26, 2021

Co-Diagnostics, Inc.
2401 South Foothill Dr, Suite D
Salt Lake City, Utah 84109
United States

1 (801) 438-1036

info@codiagnostics.com

© 2016-2020 Co-Diagnostics, Inc. • All Rights Reserved.

LATEST NEWS RELEASE

Co-Diagnostics is a molecular diagnostics company with a unique mathematical approach to DNA test design. Our products offer a unique value proposition, making the detection of infectious disease and genetic disorders far more affordable worldwide.

Click here to learn more

Co-Diagnostics, Inc.
2401 South Foothill Dr, Suite D
Salt Lake City, Utah 84109
United States

1 (801) 438-1036

info@codiagnostics.com

COMPANY

 

© 2016-2020 Co-Diagnostics, Inc. • All Rights Reserved.